FDA Inspection 822730 — Swedish Orphan Biovitrum AB (Publ)
The FDA completed an inspection of Swedish Orphan Biovitrum AB (Publ) on February 22, 2013 in Stockholm. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 22, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Stockholm (Sweden)